A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Saved in:
| Title: | A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. |
|---|---|
| Authors: | Lontos, Konstantinos1 (AUTHOR), Tsagianni, Anastasia1 (AUTHOR), Agha, Mounzer1 (AUTHOR), Raptis, Anastasios1 (AUTHOR), Hou, Jing-Zhou1 (AUTHOR), Farah, Rafic1 (AUTHOR), Redner, Robert L.1 (AUTHOR), Im, Annie1 (AUTHOR), Dorritie, Kathleen A.1 (AUTHOR), Sehgal, Alison1 (AUTHOR), Rossetti, James1 (AUTHOR), Aggarwal, Nidhi2 (AUTHOR), Saul, Melissa3 (AUTHOR), Gooding, William4 (AUTHOR), Boyiadzis, Michael1 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Dec2022, Vol. 63 Issue 13, p3257-3260. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
